Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes: A Randomized Controlled Trial

NCT06820177 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT06820177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06820177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes: A Randomized Controlled Trial
Lead sponsor
University of California, San Diego
Phase
Phase 4
Overall status
Recruiting
Start date
April 22, 2025
Completion date
May 31, 2027
Enrollment
276 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

abortion, blood loss, dilation and evacuation, hemorrhage, prophylactic tranexamic acid use